The Prognostic Value of Total Tumor Volume Response Compared With RECIST1.1 in Patients With Initially Unresectable Colorectal Liver Metastases Undergoing Systemic Treatment

Objectives:. Compare total tumor volume (TTV) response after systemic treatment to Response Evaluation Criteria in Solid Tumors (RECIST1.1) and assess the prognostic value of TTV change and RECIST1.1 for recurrence-free survival (RFS) in patients with colorectal liver-only metastases (CRLM). Backgro...

Full description

Bibliographic Details
Main Authors: Nina J. Wesdorp, MD, Karen Bolhuis, MD, Joran Roor, MSc, Jan-Hein T. M. van Waesberghe, MD, PhD, Susan van Dieren, MSc, PhD, Martin J. van Amerongen, MD, PhD, Thiery Chapelle, MD, PhD, Cornelis H. C. Dejong, MD, PhD, Marc R. W. Engelbrecht, MD, PhD, Michael F. Gerhards, MD, PhD, Dirk Grunhagen, MD, PhD, Thomas M. van Gulik, MD, PhD, John J. Hermans, MSc, MD, PhD, Koert P. de Jong, MD, PhD, Joost M. Klaase, MD, PhD, Mike S. L. Liem, MD, PhD, Krijn P. van Lienden, MD, PhD, I. Quintus Molenaar, MD, PhD, Gijs A. Patijn, MD, PhD, Arjen M. Rijken, MD, PhD, Theo M. Ruers, MD, PhD, Cornelis Verhoef, MD, PhD, Johannes H. W. de Wilt, MD, PhD, Rutger-Jan Swijnenburg, MD, PhD, Cornelis J. A. Punt, MD, PhD, Joost Huiskens, MD, PhD, Geert Kazemier, MD, PhD, for the Dutch Colorectal Cancer Group Liver Expert Panel
Format: Article
Language:English
Published: Wolters Kluwer Health 2021-12-01
Series:Annals of Surgery Open
Online Access:http://journals.lww.com/10.1097/AS9.0000000000000103